5 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 0.2% per year over the past 4 years.
Net income has grown slower than revenue (-20.8% vs 0.2% per year).
Financial health
Total debt ($14.1B) exceeds cash ($1.1B); net debt is $12.9B.
Total debt has grown faster than revenue (44.6% vs 0.2% per year).
Shareholder returns
Dividends have been paid for 5 consecutive years, consuming 56.3% of earnings.
The dividend has grown 12.3% per year over the past 4 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$16.9B
$816M
20.1%
0.0%
-$879M
$14.1B
$1.1B
2024
$15.6B
$1.1B
21.8%
0.0%
$524M
$6.2B
$3.3B
2023
$17.8B
$2.2B
27.2%
0.0%
$2.2B
$4.9B
$2.6B
2022
$21.1B
$1.6B
17.5%
0.0%
-$6.1B
$4.7B
$1.1B
2021
$16.8B
$2.1B
20.0%
0.0%
-$3.3B
—
$902M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$4.7B
$68M
16.4%
0.0%
-$877M
$14.6B
$839M
Dec '25
$4.9B
$95M
20.7%
0.0%
$809M
$14.1B
$1.1B
Sep '25
$4.4B
$166M
24.3%
0.0%
$385M
$15.6B
$1.3B
Jun '25
$4.0B
$354M
18.4%
0.0%
-$1.5B
$11.3B
$6.8B
Mar '25
$3.7B
$201M
16.3%
0.0%
-$595M
$6.7B
$3.2B
Dec '24
$4.0B
$602M
27.0%
0.0%
$564M
$6.2B
$3.3B
Sep '24
$3.9B
$221M
19.9%
0.0%
$973M
$6.2B
$2.8B
Jun '24
$3.7B
$70M
17.8%
0.0%
-$1.8B
$5.0B
$1.2B
Mar '24
$3.9B
$244M
22.2%
0.0%
$758M
$5.1B
$2.9B
Dec '23
$4.4B
$616M
28.7%
0.0%
$1.1B
$4.9B
$2.6B
Sep '23
$4.4B
$373M
24.0%
0.0%
$1.1B
—
$2.2B
Jun '23
$4.4B
$622M
31.1%
0.0%
-$827M
—
$1.3B
Mar '23
$4.7B
$632M
25.0%
0.0%
$758M
—
$3.1B
Dec '22
—
$336M
—
—
—
$4.7B
$1.1B
Sep '22
—
$380M
—
—
—
—
—
Jun '22
—
$206M
—
—
—
—
—
Mar '22
—
$688M
—
—
—
—
—
Valuation over time
How the market has priced BG against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 11.5× (Mar '23) to 26.5× (Jun '26).
The price-to-sales ratio has risen from 0.9× (Mar '23) to 1.3× (Jun '26).
The dividend yield has risen from 1.9% (Mar '23) to 2.1% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is BG growing its revenue and profit?
Over the past 4 years, Bunge Global's revenue has grown 0.2% per year, and net income declined 20.8% per year. These are computed facts, not advice.
How much debt does BG have?
As of FY2025, Bunge Global reported $14.1B of total debt against $1.1B of cash.
What is BG's profit margin?
In FY2025, gross margin was 20.1%, operating margin —, and net margin 4.8%.
What is BG's P/E ratio?
As of Jun '26, Bunge Global traded at a price-to-earnings ratio of about 26.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.